Currently Viewing:
Currently Reading
AHA, Google Life Sciences Announce $50M Collaboration to Find Drivers of Heart Disease
November 08, 2015 – Mary K. Caffrey
Nation's Top Mental Health Official Headed to Google
September 15, 2015 – Mary K. Caffrey
Young at Heart? Most Americans Aren't, CDC Research Finds
September 03, 2015 – Mary K. Caffrey
Hepatitis C Patients Also Have Increased Risk of Heart Disease
August 15, 2015 – Laura Joszt
CVS to Wait for 2nd Approval Before Seeking Prices on PCSK9 Inhibitors
August 10, 2015 – Mary K. Caffrey
FDA Approves Alirocumab, First of Cholesterol-Fighting PCSK9 Inhibitors to Hit US Market
July 24, 2015 – Mary K. Caffrey
ACA Coverage Expansion Expected to Reduce Cardiovascular Deaths
July 12, 2015 – Cate Douglass
US Surgeon General Wants to Focus on Prevention
April 23, 2015
Medicare Part D Saved 27,000 People With CVD Treatment Access
February 23, 2015

AHA, Google Life Sciences Announce $50M Collaboration to Find Drivers of Heart Disease

Mary K. Caffrey
The venture will select a project leader in early 2016. AHA said this is the largest single research investment in its history.
The American Heart Association (AHA) and Google Life Sciences on Sunday announced a $50 million partnership to fund research into the causes of heart disease. Each organization will invest $25 million in the effort, which AHA said is the largest one-time research investment in the group’s history.

The announcement came in an afternoon session at AHA’s Scientific Sessions, which opened Saturday and conclude Wednesday in Orlando, Florida.

According to a statement from AHA, in early 2016, a joint leadership group of AHA and Google Life Sciences members will select a point person to run the venture. The statement said the person may be a cardiologist but could come from another field, will receive control of the $50 million in phases to run the program.

It was described as a “cross functional group of investigators, and lead all efforts towards further finding new causes and drivers of coronary heart disease.” Aspects will cover clinical research, engineering, and data analysis, as well as access to support from both Google Life Sciences and AHA.

“With its devastating human impact on countless generations of families, cardiovascular disease, and in particular coronary heart disease remains the greatest and deadliest global health challenge we face today,” said AHA CEO Nancy Brown.

Sunday’s announcement emphasized the role that technology will play in the project. “This is a fundamentally different kind of model for funding innovation,” said Andy Conrad, CEO of Google Life Sciences. “The team leader will be able to bring together clinicians, engineers, designers, basic researchers and other experts to think in new ways about the causes of coronary heart disease.”

Copyright AJMC 2006-2020 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome the the new and improved, the premier managed market network. Tell us about yourself so that we can serve you better.
Sign Up